Pathways’ Picks January 8: A Global Post-Holiday Catch-up


In this edition of Pathways’ Picks: a rundown of important items you might have missed from the US, Europe, and around the world, on topics including diagnostics reimbursement, third-party 510(k) review, the EU Medical Device Regulation, new China guides on device development, and regulatory timelines in India.

Welcome to 2020! Important medtech regulatory and policy news continued to flow through the holiday and New Year’s period. We’ll catch you up on the most important happenings globally in this latest edition of Pathways’ Picks

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: